News | September 20, 2010

TrueBeam Treatment System Debuts in Europe

Varian's RapidArc was displayed at ESTRO.

September 20, 2010 — A new radiotherapy treatment device was displayed for the first time in Europe at the annual meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), held September 12-16, in Barcelona.

Varian Medical Systems had its new TrueBeam medical linear accelerator on display at its booth. TrueBeam uses a multitude of technical innovations to dynamically synchronize imaging, patient positioning, motion management and treatment delivery.

Designed to be a best-in-class and versatile platform, TrueBeam can be used for all forms of advanced external-beam radiotherapy, including image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT) and RapidArc radiotherapy. The product line includes TrueBeam STx, specially configured for advanced radiosurgery.

With its high-intensity mode, TrueBeam can deliver doses at up to 2,400 MU/min., more than twice as fast as any other machine for either radiotherapy or radiosurgery. Planning of such rapid treatments is fully supported in the latest version of Varian's Eclipse treatment planning system.

Also on display was Varian's new Gated RapidArc capability, which enables the use of RapidArc technology in combination with respiratory gating – a process of turning the beam on and off in synchrony with the patient's breathing – during either radiotherapy or radiosurgery. This technology helps to improve the precision of treatment delivery by compensating for tumor motion. Gated RapidArc is available as an upgrade for Trilogy and Clinac iX accelerators.

The company's unique low-energy medical linear accelerator for image guided RapidArc IMRT treatments in international clinics was displayed, along with the latest version of the Aria oncology information management software.

Varian's Particle Therapy group introduced its fully-integrated ProBeam proton therapy system at the show as well. The ProBeam system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians.

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation